Collegium Pharmaceutical, Inc. (COLL) vs Evolus, Inc. (EOLS)

Collegium Pharmaceutical, Inc. and Evolus, Inc. are both Drug Manufacturers Specialty & Generic companies. Collegium Pharmaceutical, Inc. is the larger, with a market value of $737.1M against $519.2M — 1.4× the size. Evolus, Inc. has negative trailing earnings, so its P/E is not meaningful; Collegium Pharmaceutical, Inc. trades at 14.7×. Collegium Pharmaceutical, Inc. grew revenue faster over the last twelve months: 14.3% against 13.9%. Collegium Pharmaceutical, Inc. has the higher net margin (5.93% vs −10.9%) and the higher return on invested capital (7.85% vs −14.5%). Across the 18 metrics below, Collegium Pharmaceutical, Inc. leads on 9 and Evolus, Inc. on 9.